Back
Brookline Bancorp Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
28
BRKL
Brookline Bancorp
Last Price:
10.44
Seasonality Move:
2.8%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
61.00
Seasonality Move:
0.29%
Sell
28
Brookline Bancorp (BRKL)
is a Sell
Is Brookline Bancorp a Buy, Sell or Hold?
- The current Brookline Bancorp [BRKL] share price is $10.29. The Score for BRKL is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BRKL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BRKL Stock Price Chart
What is Brookline Bancorp's stock price today?
-
The Brookline Bancorp share price today is $10.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRKL is experiencing slight buying pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing slight selling pressure.
BRKL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 62.9 | Buy |
| Chaikin Money Flow: | 51790 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.75 - 10.15) | Buy |
| Bollinger Bands (100): | (8.49 - 9.99) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 52.65 | Buy |
| Chaikin Money Flow: | -163397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.84 - 62.92) | Buy |
| Bollinger Bands (100): | (59.73 - 65.45) | Sell |
BRKL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.97 | Buy |
| 20-day SMA: | 10.01 | Buy |
| 50-day SMA: | 9.92 | Buy |
| 200-day SMA: | 9.65 | Buy |
| 8-day EMA: | 10.05 | Buy |
| 20-day EMA: | 9.97 | Buy |
| 50-day EMA: | 9.77 | Buy |
| 200-day EMA: | 9.6 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.54 | Buy |
| 20-day SMA: | 60.34 | Buy |
| 50-day SMA: | 61.2 | Sell |
| 200-day SMA: | 61.23 | Sell |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 59.62 | Buy |
| 50-day EMA: | 60.85 | Buy |
| 200-day EMA: | 60.54 | Buy |
Brookline Bancorp Earnings Growth & BRKL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.21 per share, and an increase next year of $0.20 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Brookline Bancorp Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||